USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $0.74, $0.20 better than the analyst estimate of $0.54. Revenue for the quarter came in at $236 million versus the consensus estimate of $225.2 million.

GUIDANCE:

USANA Health Sciences sees FY2025 EPS of $2.35-$3.00, versus the consensus of $2.61. USANA Health Sciences sees FY2025 revenue of $920-1000 million, versus the consensus of $947 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.